Insider trade

Danaher Corporation (DHR): Director received 181.55 units

Raymond C Stevens, Director at Danaher Corporation, reported a grant / award of 181.55 units.

181.55
Derivative units · @ $194.98
Traded
Jul 31, 2026
Filed
Aug 4, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 27, 2026CongressDisclosed purchase of DHR — reported range $1,001 - $15,000
  2. Jun 3, 2026Company filing · Form 8-K · New debt, Other newsTook on new debt or obligations, and reported other company news
  3. Jul 21, 2026Company filing · Form 8-K · ResultsReported its results
  4. Jul 31, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors (and 1 more item)“On August 3, 2026, Danaher Corporation (the “Company” or “Danaher”) announced that, effective as of October 1, 2026 (the “Effective Date”), the Board of Directors of the Company (the “Board”) has appointed Julie Sawyer Montgomery as President and Chief Executive Officer of the Company (the “CEO”).”

What came next

  1. Aug 7, 2026FDAFDA device clearance: Xpert Hemorrhagic Fever
  2. Aug 7, 2026FDAFDA device clearance: Aperio iQC DX Software
  3. Aug 7, 2026FDAFDA device clearance: Aperio GT 450 DX; Aperio GT 180 DX
  4. Aug 12, 2026FDARecall: DxU 840m Iris, REF: C76947; DxU 850m Iris, REF: C49513
  5. Aug 12, 2026FDARecall: IQ200 SPRINT, REF: 700-3322,700-3322RFB, 700-3325, 700-3326, B48997; IQ200 SELECT, REF: 700-3340, 700-3345, 700-3347, B48998, C10684; IQ200 ELITE, REF: 700-337…
  6. Aug 18, 2026FDARecall: The ABL90 FLEX and ABL90 FLEX PLUS analyzers are intended for use by trained technologists, nurses, physicians and therapists. It is intended for use in a labo…
  7. Aug 21, 2026Insider · 1 personInsiders: 3 sales (~$12.7M)
  8. Aug 31, 2026CongressDisclosed sale of DHR — reported range $15,001 - $50,000
  9. Sep 2, 2026FDARecall: DxC 500 AU Clinical Chemistry Analyzers: 1. AU w/out ISE, Part No. C63519 2. AU w/ISE, Part No. C63520
  10. Sep 2, 2026FDARecall: DxC 500i Clinical Analyzer Modules: 1. DxC 500 AU Module w/ISE, DxC 500i, Part No. C63522 2. DxC 500 AU Module, DxC 500i, Part No. C63521 3. Access 2 Module, D…
  11. Sep 2, 2026CongressDisclosed partial sale of DHR — reported range $1,001 - $15,000
  12. Sep 21, 2026FDAFDA device clearance: Access NT-proBNP
  13. Sep 21, 2026FDARecall: ROTOR ASSY-SW41, Reference Number 331362, when the rotors are installed in the following centrifuges: Optima XPN-100 (Model Numbers A99846 and A94469), Optima…
  14. Sep 21, 2026FDARecall: ROTOR ASSY-SW40, Reference Number 331302, when the rotors are installed in the following centrifuges: Optima XPN-100 (Model Numbers A99846 and A94469), Optima…
  15. Sep 25, 2026FDAFDA device clearance: Xpert Respiratory Panel
  16. Oct 9, 2026Company filing · Form 8-K · Executive change, Other newsChanged a top executive or board member, and reported other company news“On October 9, 2026, the Board of Directors (the “Board”) of Danaher Corporation (the “Company” or “Danaher”) increased the size of the Board to thirteen members and appointed Daniel L. Comas and Robert M. Hershberg to the Board, in each case effective immediately.”
  17. Oct 19, 2026FDAFDA device clearance: Access MeMed BV
  18. Oct 20, 2026FDAFDA device clearance: Access BNP II
  19. Oct 21, 2026Company filing · Form 8-K · ResultsReported its results
  20. Oct 28, 2026Insider · 2 peopleInsiders: 4 sales (~$8.8M)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Danaher Corporation

For Danaher Corporation, OQRO holds 14 insider filings (SEC Form 4 or Form 144), 2 Congress trade reports and 7 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DHR page.

How this filing works

Explore the data

Common questions

Which Danaher Corporation (DHR) insider traded, and how much?

Raymond C Stevens, Director at Danaher Corporation, reported a grant / award of 181.55 units. At $194.98.

When did it happen, and when was it made public?

Traded: Jul 31, 2026. Filed: Aug 4, 2026. That is 4 days between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Danaher Corporation recently?

For Danaher Corporation, OQRO holds 14 insider filings (SEC Form 4 or Form 144), 2 Congress trade reports and 7 fund holdings reports (13F) dated in the last 90 days. They are listed on the DHR page.

Does this mean DHR stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Danaher Corporation

Everything OQRO holds on this company is on its DHR page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data